352 related articles for article (PubMed ID: 25374320)
1. Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010.
Sun S; Cohen CJ; Dehnhardt CM
Pharm Pat Anal; 2014 Sep; 3(5):509-21. PubMed ID: 25374320
[TBL] [Abstract][Full Text] [Related]
2. The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na(v)1.7.
Sun S; Jia Q; Zenova AY; Chafeev M; Zhang Z; Lin S; Kwan R; Grimwood ME; Chowdhury S; Young C; Cohen CJ; Oballa RM
Bioorg Med Chem Lett; 2014 Sep; 24(18):4397-4401. PubMed ID: 25176194
[TBL] [Abstract][Full Text] [Related]
3. Selective Ligands and Drug Discovery Targeting the Voltage-Gated Sodium Channel Nav1.7.
Payandeh J; Hackos DH
Handb Exp Pharmacol; 2018; 246():271-306. PubMed ID: 29532179
[TBL] [Abstract][Full Text] [Related]
4. Na
McKerrall SJ; Sutherlin DP
Bioorg Med Chem Lett; 2018 Oct; 28(19):3141-3149. PubMed ID: 30139550
[TBL] [Abstract][Full Text] [Related]
5. Discovery of (phenoxy-2-hydroxypropyl)piperidines as a novel class of voltage-gated sodium channel 1.7 inhibitors.
Suzuki S; Kuroda T; Kimoto H; Domon Y; Kubota K; Kitano Y; Yokoyama T; Shimizugawa A; Sugita R; Koishi R; Asano D; Tamaki K; Shinozuka T; Kobayashi H
Bioorg Med Chem Lett; 2015 Nov; 25(22):5419-23. PubMed ID: 26358159
[TBL] [Abstract][Full Text] [Related]
6. Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1.
Murray JK; Biswas K; Holder JR; Zou A; Ligutti J; Liu D; Poppe L; Andrews KL; Lin FF; Meng SY; Moyer BD; McDonough SI; Miranda LP
Bioorg Med Chem Lett; 2015 Nov; 25(21):4866-4871. PubMed ID: 26112439
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Spider (
Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
[TBL] [Abstract][Full Text] [Related]
8. Structure and activity relationship in the (S)-N-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockers.
Kers I; Csjernyik G; Macsari I; Nylöf M; Sandberg L; Skogholm K; Bueters T; Eriksson AB; Oerther S; Lund PE; Venyike E; Nyström JE; Besidski Y
Bioorg Med Chem Lett; 2012 Sep; 22(17):5618-24. PubMed ID: 22832315
[TBL] [Abstract][Full Text] [Related]
9. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a Novel Class of State-Dependent Na
Tanaka K; Kobayashi H; Suzuki S; Shibuya S; Kimoto H; Domon Y; Kubota K; Kitano Y; Yokoyama T; Shimizugawa A; Koishi R; Fujiwara C; Asano D; Shinozuka T
Chem Pharm Bull (Tokyo); 2020; 68(7):653-663. PubMed ID: 32612000
[TBL] [Abstract][Full Text] [Related]
11. Discovery of morpholine-based aryl sulfonamides as Na
Wu YJ; Guernon J; McClure A; Venables B; Rajamani R; Robbins KJ; Knox RJ; Matchett M; Pieschl RL; Herrington J; Bristow LJ; Meanwell NA; Olson R; Thompson LA; Dzierba C
Bioorg Med Chem Lett; 2018 Mar; 28(5):958-962. PubMed ID: 29439904
[TBL] [Abstract][Full Text] [Related]
12. Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor.
Flinspach M; Xu Q; Piekarz AD; Fellows R; Hagan R; Gibbs A; Liu Y; Neff RA; Freedman J; Eckert WA; Zhou M; Bonesteel R; Pennington MW; Eddinger KA; Yaksh TL; Hunter M; Swanson RV; Wickenden AD
Sci Rep; 2017 Jan; 7():39662. PubMed ID: 28045073
[TBL] [Abstract][Full Text] [Related]
13. Sulfonamides as Selective Na
Graceffa RF; Boezio AA; Able J; Altmann S; Berry LM; Boezio C; Butler JR; Chu-Moyer M; Cooke M; DiMauro EF; Dineen TA; Feric Bojic E; Foti RS; Fremeau RT; Guzman-Perez A; Gao H; Gunaydin H; Huang H; Huang L; Ilch C; Jarosh M; Kornecook T; Kreiman CR; La DS; Ligutti J; Milgram BC; Lin MJ; Marx IE; Nguyen HN; Peterson EA; Rescourio G; Roberts J; Schenkel L; Shimanovich R; Sparling BA; Stellwagen J; Taborn K; Vaida KR; Wang J; Yeoman J; Yu V; Zhu D; Moyer BD; Weiss MM
J Med Chem; 2017 Jul; 60(14):5990-6017. PubMed ID: 28324649
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa
Neff RA; Flinspach M; Gibbs A; Shih AY; Minassian NA; Liu Y; Fellows R; Libiger O; Young S; Pennington MW; Hunter MJ; Wickenden AD
J Biol Chem; 2020 Jan; 295(5):1315-1327. PubMed ID: 31871053
[TBL] [Abstract][Full Text] [Related]
15. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens.
Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ
Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003
[TBL] [Abstract][Full Text] [Related]
16. In silico exploration of aryl sulfonamide analogs as voltage-gated sodium channel 1.7 inhibitors by using 3D-QSAR, molecular docking study, and molecular dynamics simulations.
Wang M; Wang Y; Kong D; Jiang H; Wang J; Cheng M
Comput Biol Chem; 2018 Dec; 77():214-225. PubMed ID: 30359866
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic Ligation of a Pore Blocker Toxin and a Gating Modifier Toxin: Creating Double-Knotted Peptides with Improved Sodium Channel Na
Tran HNT; Tran P; Deuis JR; Agwa AJ; Zhang AH; Vetter I; Schroeder CI
Bioconjug Chem; 2020 Jan; 31(1):64-73. PubMed ID: 31790574
[TBL] [Abstract][Full Text] [Related]
18. The discovery of benzoxazine sulfonamide inhibitors of Na
La DS; Peterson EA; Bode C; Boezio AA; Bregman H; Chu-Moyer MY; Coats J; DiMauro EF; Dineen TA; Du B; Gao H; Graceffa R; Gunaydin H; Guzman-Perez A; Fremeau R; Huang X; Ilch C; Kornecook TJ; Kreiman C; Ligutti J; Jasmine Lin MH; McDermott JS; Marx I; Matson DJ; McDonough SI; Moyer BD; Nho Nguyen H; Taborn K; Yu V; Weiss MM
Bioorg Med Chem Lett; 2017 Aug; 27(15):3477-3485. PubMed ID: 28629594
[TBL] [Abstract][Full Text] [Related]
19. Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.
Murray JK; Ligutti J; Liu D; Zou A; Poppe L; Li H; Andrews KL; Moyer BD; McDonough SI; Favreau P; Stöcklin R; Miranda LP
J Med Chem; 2015 Mar; 58(5):2299-314. PubMed ID: 25658507
[TBL] [Abstract][Full Text] [Related]
20. New aryl and acylsulfonamides as state-dependent inhibitors of Na
Zidar N; Tomašič T; Kikelj D; Durcik M; Tytgat J; Peigneur S; Rogers M; Haworth A; Kirby RW
Eur J Med Chem; 2023 Oct; 258():115530. PubMed ID: 37329714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
